期刊文献+

NKT细胞与移植物抗宿主病 被引量:3

NKT Cells and Graft-Versus-Host Disease——Review
下载PDF
导出
摘要 NKT细胞(自然杀伤T细胞)是一种免疫T细胞,同时表达传统T细胞和自然杀伤细胞的表面标志,经特异抗原刺激后能够分泌大量细胞因子,调节Th1/Th2平衡,在预防和治疗移植物抗宿主病方面发挥重要作用。与此同时,NKT细胞能够发挥抗肿瘤和抗感染效应,进而加大了NKT细胞在异基因造血干细胞移植方面的应用,帮助患者重建移植后免疫。因此,进一步了解NKT细胞生物学和免疫学特征及其具体免疫调节机制,对运用NKT细胞防治移植中出现移植物抗宿主病有重要的指导意义。本文就NKT细胞的生物学特征、分类、分化发育,免疫活化及NKT细胞与GVHD(包括机制)、NKT细胞与肿瘤、NKT细胞与感染和NKT细胞与临床GVHD研究进行综述。 NKT cells (nature killer T cells), as a regulatory cellular compartment in the immune system, express cell surface markers of T cells and NK cells. It secretes a variety of cytokines that stimulat specific antigens. Through regulating the balance of Thl/Th2, the NKT ceils play an important role in prevention and treatment of graft-versus-host disease (GVHD). Its antitumor and anti-infectious effects serve as a basis of its application in allogeneic hematopoietic stem cell transplantation. A better understanding of the biological and immunological features of NKT cell, as well as its specific immune regulatory mechanisms, will further justify the rationales of using NKT ceils in the management of GVHD for patients. In this review, the biologic properties, classification, differentiation and development, immune cativation of NKT cells as well as the NKT cells and GVHD including the related mechanisms of prevention and treatment of GVHD with NKT cells,NKT cells and tumors ,NKT cells and infection,and NKT cells and clinical GVHD are summarized.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第5期1345-1350,共6页 Journal of Experimental Hematology
基金 科技部973项目(编号2011CB964801,2010CB945204) 国家医药重大专项(编号2011ZX09102-010-04) 国家自然基金(编号81090410,30825017,30971110)
  • 相关文献

参考文献36

  • 1Kolb HJ.Graft-versus-leukemia effects of transplantation and donor lymphocytes.Blood,2008;112(12):4371-4383.
  • 2杨洁,刘嬿,聂晓绚,任亚娜,范华骅.Vα14iNKT细胞对异基因骨髓移植GVHD具有抑制作用[J].现代免疫学,2009,29(3):190-195. 被引量:2
  • 3Yang J,Gao L,Liu Y,et al.Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.Transfusion,2010 ;50 (2):407-417.
  • 4Kim JH,Choi EY,Chung DH.Donor bone marrow type Ⅱ (nonValphal4Jalpha18 CD1d-restricted) NKT cells suppress graftversus-host disease by producing IFN-gamma and IL-4.J Immunol,2007 ; 179 (10):6579-6587.
  • 5Godfrey D I,Macdonald HR,Kronenberg M,et al.NKT cells:what's in a name? Nat Rev Immunol,2004; 4(3):231-237.
  • 6Bendelac A,Savage PB,Teyton L.The biology of NKT cells.Annu Rev Immuno1,2007 ;25:297-336.
  • 7Engel I,Kronenberg M.Making memory at birth:understanding the differentiation of natural killer T cells.Curr Opin Immunol,2012 ;24(2):184-190.
  • 8Kronenberg M,Engel I.On the road:progress in finding the unique pathway of invariant NKT cell differentiation.Curr Opin Immunol,2007 ; 19 (2):186-193.
  • 9Porubsky S,Speak AO,Luckow B,et al.Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.Proc Natl Acad Sci USA,2007 ; 104 (14):5977-5982.
  • 10Reilly EC,Wands JR,Brossay L.Cytokine dependent and independent iNKT cell activation.Cytokine,2010 ; 51 (3):227-231.

二级参考文献10

  • 1何祎,冯四洲,王玫,魏嘉璘,秦铁军,周征,翟文静,邱录贵,韩明哲.HLA相合同胞异基因造血干细胞移植治疗慢性粒细胞白血病第1次慢性期51例分析[J].中华血液学杂志,2005,26(7):389-392. 被引量:15
  • 2范华骅,郑滨,刘嬿,高跞,聂晓绚,高峰,陆华中.人外周血自然杀伤T细胞体外扩增及其功能的初步研究[J].现代免疫学,2005,25(5):398-401. 被引量:5
  • 3Shlomchik WD. Graft versus host disease[J]. Nat Rev Immunol, 2007,7: 340-352.
  • 4Bendelac A, Savage PB, Teyton L. The biology of NKT cells [J]. Annu Rev Immunol, 2007, 25:297-336.
  • 5Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin [J]. Blood, 1996,88:3230-3239.
  • 6Hashimoto D, Asakura S, Miyake S, et al. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor Tcells[J].J Immunol, 2005,174:551-556.
  • 7Haraguchi K, Takahashi T, Matsumoto A, et al. Hostresidual invariant NK T cells attenuate graft-versus-host immunity [J].J Immunol, 2005,175: 1320-1328.
  • 8Nieda M, Okai M, Tazbirkova A, et al. Therapeutic activation of Vα24^+ Vβ11^+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity [J]. Blood, 2004,103:383-389.
  • 9J. Vela-Ojeda,M. A. García-Ruiz Esparza,E. Reyes-Maldonado,L. Jiménez-Zamudio,E. García-Latorre,M. Moreno-Lafont,I. Estrada-García,L. Montiel-Cervantes,F. Tripp-Villanueva,M. Ayala-Sánchez,L. D. García-León,J. R. Borbolla-Escoboza,H. Mayani. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation[J] 2006,Annals of Hematology(2):113~120
  • 10黄勇,姜尔烈,周征,刘庆国,翟文静,冯四洲,韩明哲.Vα24 NKT细胞的细胞因子生成调控[J].临床血液学杂志,2008,21(3):264-267. 被引量:2

共引文献2

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部